| Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies (NCT00068523) | Case Comprehensive Cancer Center | 2003-06-01 |
| VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies (NCT00070538) | Vion Pharmaceuticals | 2003-06-01 |
| Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00089037) | Fred Hutchinson Cancer Center | 2003-06-01 |
| Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality (NCT00065156) | Celgene | 2003-06-01 |
| Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias (NCT00061763) | Novartis Pharmaceuticals | 2003-05-01 |
| Paricalcitol in Treating Patients With Myelodysplastic Syndrome (NCT00064376) | Cedars-Sinai Medical Center | 2003-05-01 |
| Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation (NCT00148980) | Hadassah Medical Organization | 2003-04-01 |
| Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00062140) | Fred Hutchinson Cancer Center | 2003-04-01 |
| Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00112567) | Fred Hutchinson Cancer Center | 2003-04-01 |
| 3-AP and Cytarabine in Treating Patients With Hematologic Cancer (NCT00064090) | Vion Pharmaceuticals | 2003-03-01 |
| Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders (NCT00055653) | Roswell Park Cancer Institute | 2003-01-01 |
| Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200 (NCT00455910) | Groupe Francophone des Myelodysplasies | 2003-01-01 |
| Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer (NCT00627666) | Asan Medical Center | 2003-01-01 |
| Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer (NCT00265837) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-12-01 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer (NCT00053196) | Alliance for Clinical Trials in Oncology | 2002-12-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer (NCT00304018) | University of California, San Francisco | 2002-10-01 |
| Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder (NCT00054340) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia (NCT00046930) | Eastern Cooperative Oncology Group | 2002-09-17 |
| Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT00052832) | University of Wisconsin, Madison | 2002-09-01 |
| Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS (NCT00053287) | Case Comprehensive Cancer Center | 2002-09-01 |
| Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes (NCT00028899) | Children's Oncology Group | 2002-07-01 |
| Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer (NCT00255710) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-07-01 |
| Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899) (NCT00044486) | Merck Sharp & Dohme LLC | 2002-07-01 |
| Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia (NCT00053157) | Roswell Park Cancer Institute | 2002-06-01 |
| Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers (NCT00899795) | OHSU Knight Cancer Institute | 2002-06-01 |
| FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma (NCT00042822) | Memorial Sloan Kettering Cancer Center | 2002-05-01 |
| Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia (NCT00054236) | Case Comprehensive Cancer Center | 2002-05-01 |
| Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome (NCT00035867) | Telik | 2002-04-01 |
| Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer (NCT00062231) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-04-01 |
| VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome (NCT00049686) | Vion Pharmaceuticals | 2002-04-01 |
| Pyroxamide in Treating Patients With Advanced Cancer (NCT00042900) | Memorial Sloan Kettering Cancer Center | 2002-04-01 |
| Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy (NCT00303719) | Masonic Cancer Center, University of Minnesota | 2002-03-26 |
| A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) (NCT00230321) | Peter L Greenberg | 2002-02-01 |
| PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2) (NCT00045942) | Novartis Pharmaceuticals | 2002-01-30 |
| NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders (NCT00053989) | Roswell Park Cancer Institute | 2002-01-29 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder (NCT00049634) | Fred Hutchinson Cancer Center | 2002-01-01 |
| Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00301912) | University of California, San Francisco | 2002-01-01 |
| Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation (NCT00036712) | Medical College of Wisconsin | 2002-01-01 |
| Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML (NCT00069992) | Baylor College of Medicine | 2001-12-01 |
| Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders (NCT00186576) | Stanford University | 2001-12-01 |
| T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies (NCT00683046) | University of Chicago | 2001-11-01 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders (NCT00544115) | City of Hope Medical Center | 2001-10-16 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00027924) | Fred Hutchinson Cancer Center | 2001-10-01 |
| Gemtuzumab in Treating Patients With Myelodysplastic Syndrome (NCT00022321) | Jonsson Comprehensive Cancer Center | 2001-09-01 |
| Blood and Marrow Transplant Clinical Research Network (NCT00023530) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-09-01 |
| Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes (NCT00030069) | University of Pittsburgh | 2001-09-01 |
| Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome (NCT00030550) | Roswell Park Cancer Institute | 2001-09-01 |
| S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome (NCT00016419) | SWOG Cancer Research Network | 2001-08-01 |
| Bevacizumab in Treating Patients With Myelodysplastic Syndrome (NCT00022048) | Stanford University | 2001-08-01 |
| Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer (NCT00028730) | Memorial Sloan Kettering Cancer Center | 2001-08-01 |
| A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes (NCT00050843) | Celgene Corporation | 2001-08-01 |
| Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00027560) | Memorial Sloan Kettering Cancer Center | 2001-07-01 |
| Proteases in Patients With Prostate Cancer That Has Spread to the Bone (NCT00899665) | Barbara Ann Karmanos Cancer Institute | 2001-07-01 |
| Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) (NCT00034684) | Merck Sharp & Dohme LLC | 2001-07-01 |
| Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome (NCT00053001) | Fallon Clinic | 2001-06-01 |
| The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen (NCT01890486) | Wake Forest University Health Sciences | 2001-05-21 |
| Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS (NCT00025662) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-05-01 |
| Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer (NCT00290641) | Masonic Cancer Center, University of Minnesota | 2001-04-01 |
| Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers (NCT00015951) | University of Maryland, Baltimore | 2001-04-01 |
| Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes (NCT00020969) | CTI BioPharma | 2001-03-01 |
| Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML (NCT00003407) | Rush University Medical Center | 2001-02-13 |
| Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome (NCT00024050) | Fred Hutchinson Cancer Center | 2001-02-01 |
| MS-275 in Treating Patients With Hematologic Cancer (NCT00015925) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2001-02-01 |
| Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant (NCT00571662) | University of Nebraska | 2000-12-08 |
| Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer (NCT00014469) | Memorial Sloan Kettering Cancer Center | 2000-12-01 |
| Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer (NCT00006239) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-12-01 |
| Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation (NCT00014482) | Memorial Sloan Kettering Cancer Center | 2000-12-01 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00054327) | Case Comprehensive Cancer Center | 2000-11-01 |
| Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer (NCT00014495) | Memorial Sloan Kettering Cancer Center | 2000-11-01 |
| Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment (NCT00006348) | Alliance for Clinical Trials in Oncology | 2000-10-01 |
| Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome (NCT00005598) | University of Michigan Rogel Cancer Center | 2000-10-01 |
| Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation (NCT00005946) | University of Maryland, Baltimore | 2000-10-01 |
| Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00008151) | Fred Hutchinson Cancer Center | 2000-10-01 |
| Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome (NCT00017550) | Genzyme, a Sanofi Company | 2000-09-01 |
| Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome (NCT00004208) | Swiss Cancer Institute | 2000-08-01 |
| Tipifarnib in Treating Patients With Advanced Hematologic Cancer (NCT00005967) | National Cancer Institute (NCI) | 2000-08-01 |
| Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (NCT00010283) | Fred Hutchinson Cancer Center | 2000-07-01 |
| Non-Ablative Allo HSCT For Hematologic Malignancies or SAA (NCT00006379) | Case Comprehensive Cancer Center | 2000-06-01 |
| Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer (NCT00365287) | Masonic Cancer Center, University of Minnesota | 2000-06-01 |
| Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00004871) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-05-01 |
| Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer (NCT00006019) | Memorial Sloan Kettering Cancer Center | 2000-05-01 |
| PS-341 in Treating Patients With Hematologic Cancer (NCT00006098) | Memorial Sloan Kettering Cancer Center | 2000-04-01 |
| Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia (NCT00006040) | Memorial Sloan Kettering Cancer Center | 2000-04-01 |
| Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter (NCT00006083) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood (NCT00146055) | University of Michigan Rogel Cancer Center | 2000-03-01 |
| Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood (NCT00143884) | University of Michigan Rogel Cancer Center | 2000-03-01 |
| Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia (NCT00005892) | Fairview University Medical Center | 2000-03-01 |
| Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer (NCT00534430) | City of Hope Medical Center | 2000-02-29 |
| S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia (NCT00005866) | SWOG Cancer Research Network | 2000-02-01 |
| Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy (NCT00005988) | Dana-Farber Cancer Institute | 2000-02-01 |
| Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation (NCT00737516) | National Marrow Donor Program | 2000-01-01 |
| Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant (NCT00716911) | City of Hope Medical Center | 2000-01-01 |
| Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00004263) | M.D. Anderson Cancer Center | 1999-12-01 |
| 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment (NCT00004239) | Alliance for Clinical Trials in Oncology | 1999-12-01 |
| Biological Therapy in Treating Patients With Myelodysplastic Syndrome (NCT00005853) | Fred Hutchinson Cancer Center | 1999-12-01 |
| Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00006042) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1999-12-01 |
| St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer (NCT00005805) | Memorial Sloan Kettering Cancer Center | 1999-12-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00005854) | Fred Hutchinson Cancer Center | 1999-12-01 |
| EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer (NCT00004258) | Indiana University | 1999-12-01 |
| Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00044954) | University of Texas Southwestern Medical Center | 1999-11-01 |